Announcements Trials
Browse Landscape

Phase

Phase NA 1

Status

Recruiting 1

Sponsor Class

OTHER 1

Study Type

Interventional 1

Sponsor

Cancer Type

Head & Neck 1

Conditions

Stress Disorders, Post-Traumatic 2Thyroid Neoplasms 1Precursor Cell Lymphoblastic Leukemia-Lymphoma 1Obsessive-Compulsive Disorder 1Neoplasms 1Melanoma, Cutaneous Malignant 1Anxiety Disorders 1

Interventions

pembrolizumab 180Gemcitabine 168Paclitaxel 150Carboplatin 134Bevacizumab 126Cisplatin 113Docetaxel 112Cyclophosphamide 109Exercise 97Nivolumab 93Fluorouracil 88Capecitabine 85Dexamethasone 81Irinotecan 74Radiotherapy 68Oxaliplatin 68Pemetrexed 66Standard of Care 64Leucovorin 63Cetuximab 59Sorafenib 53Erlotinib Hydrochloride 53Drug Therapy 53Blood Specimen Collection 51Doxorubicin 50atezolizumab 48trametinib 47Ipilimumab 47Albumin-Bound Paclitaxel 44130-nm albumin-bound paclitaxel 42

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
Interventional × Neoplasms × Eye Movement Desensitization Reprocessing × Clear all
NCT07447089 2026-03-04

EMDR Integrative Group Protocol and Individual Treatment for Patients With Cancer: A Pilot Study

Università Cattolica di Milano

Phase NA Recruiting
25 enrolled
Head & Neck

Neoplasms, Stress Disorders, Post-Traumatic, Thyroid Neoplasms

Data powered by HemOnc (CC BY 4.0) Colophon âš¡